Literature DB >> 21790115

Enhanced depth imaging optical coherence tomography.

Ian Y Wong1, Hideki Koizumi, Wico W Lai.   

Abstract

Imaging the choroid with conventional commercial spectral-domain optical coherence tomography (SD-OCT) has been difficult, mainly because of difficulty in signal transmission beyond the retinal pigment epithelium. A recent modification to the standard technique, termed enhanced depth imaging optical coherence tomography (EDI-OCT), was able to image the choroid with reasonable clarity using commercial SD-OCTs. The aim of this article was to review the technique, principle, recent findings, and possible future developments regarding EDI-OCT. A MEDLINE search on all published articles on EDI-OCT was performed up to December 2010. The principle behind EDI-OCT was discussed. Modification to the conventional technique in image acquisition was described and illustrated with figures. EDI-OCT findings in various retinal and choroidal diseases were discussed. Advantages and disadvantages were also discussed. EDI-OCT has proved to be a promising novel technique in imaging the choroid. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Year:  2011        PMID: 21790115     DOI: 10.3928/15428877-20110627-07

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  26 in total

1.  Choroidal thickness measurements in migraine patients during attack-free period.

Authors:  Emine Esra Karaca; Emine Belgin Koçer; Şengül Özdek; Hanife Tuba Akçam; Merve Bahar Ercan
Journal:  Neurol Sci       Date:  2015-08-15       Impact factor: 3.307

2.  Choroidal involvement in Rosai-Dorfman syndrome may be depicted and followed using enhanced depth imaging optical coherence tomography (EDI-OCT).

Authors:  Janelle Fassbender; Shlomit Schaal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-20       Impact factor: 3.117

3.  Enhanced depth imaging OCT (EDI-OCT) findings in acute phase of sympathetic ophthalmia.

Authors:  Bahareh Behdad; Safa Rahmani; Talieh Montahaei; Roham Soheilian; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2015-03-15       Impact factor: 2.031

4.  Choroidal thickness alterations in obstructive sleep apnea-hypopnea syndrome (OSAS).

Authors:  H A Bayhan; S Aslan Bayhan
Journal:  Eye (Lond)       Date:  2014-08-01       Impact factor: 3.775

5.  Choroidal thickness measurements in children with isolated growth hormone deficiency.

Authors:  N G Yalcin; Z Aktas; O Yuce; G D G Ikiz; M Hasanreisoglu; A Bideci
Journal:  Eye (Lond)       Date:  2017-09-15       Impact factor: 3.775

6.  Effects of enhanced depth imaging and en face averaging on optical coherence tomography angiography image quantification.

Authors:  Keke Liu; Nihaal Mehta; A Yasin Alibhai; Malvika Arya; Osama Sorour; Akihiro Ishibazawa; Iksoo Byon; Caroline R Baumal; Andre J Witkin; Jay S Duker; SriniVas R Sadda; Nadia K Waheed
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-02-04       Impact factor: 3.117

Review 7.  New developments in optical coherence tomography.

Authors:  Tigran Kostanyan; Gadi Wollstein; Joel S Schuman
Journal:  Curr Opin Ophthalmol       Date:  2015-03       Impact factor: 3.761

8.  A comprehensive enhanced depth imaging spectral-domain optical coherence tomography analysis of pseudoexfoliation spectrum from non-glaucomatous to advanced stage glaucoma in the aspect of Bruch's membrane opening-minimum rim width.

Authors:  Mustafa Hepokur; Cansu Yuksel Elgin; Medine Gunes; Fatma Sali; Halit Oguz
Journal:  Int Ophthalmol       Date:  2022-01-05       Impact factor: 2.031

Review 9.  Imaging of retinal and choroidal vascular tumours.

Authors:  H Heimann; F Jmor; B Damato
Journal:  Eye (Lond)       Date:  2012-11-30       Impact factor: 3.775

10.  Evaluation of the retinal, choroidal, and nerve fiber layer thickness changes in patients with toxic anterior segment syndrome.

Authors:  Nir Sorkin; Dafna Goldenberg; Amir Rosenblatt; Gabi Shemesh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-03       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.